For example, GoF SCN2A variants present with EIMFS might respond to sodium channel blockers, while LoF SCN2A variants present West syndrome, myoclonic atonic epilepsy, and unclassified DEEs should avoid sodium channel blockers7. The gene discussed is SCN2A; the disease is epilepsy with myoclonic atonic seizures.